Contraceptives & Hormonal Therapy

Mifepristone Tablets IP 200 mg is a synthetic steroid with potent antiprogestational and antiglucocorticoid activity on the WHO Model List of Essential Medicines. It competitively binds with high affinity to intracellular progesterone receptors, disrupting the decidua, detachment of the blastocyst, and cervical softening. Indicated for medical termination of developing intrauterine pregnancy (in combination with prostaglandin), cervical preparation prior to surgical abortion, and induction of labor in intrauterine fetal death.

Dydrogesterone Tablets IP 10 mg is an orally active retro-progesterone stereoisomer with highly selective progestogenic activity on the WHO Model List of Essential Medicines. Due to its retro-configuration, it binds selectively to progesterone receptors without significant androgenic, estrogenic, glucocorticoid, or mineralocorticoid activity, providing potent endometrial secretory transformation without inhibiting ovulation or causing metabolic side effects. Indicated for threatened and recurrent miscarriage, luteal phase support in assisted reproductive technologies (ART), endometriosis, dysmenorrhea, irregular menstrual cycles, and dysfunctional uterine bleeding.

Norethisterone (Tablets IP 5mg) is a potent first-generation synthetic 19-nortestosterone-derived progestogen on the WHO Model List of Essential Medicines. It induces profound secretory transformation of the endometrium and inhibits pituitary gonadotropin release, preventing ovulation and stabilizing the uterine vascular bed. Indicated for the treatment of dysfunctional uterine bleeding (DUB / menorrhagia), endometriosis, postponement of menstruation, secondary amenorrhea, and severe premenstrual syndrome (PMS).

Nandrolone Decanoate Injection IP (25 mg/ml, 50 mg/ml) is a synthetic 19-nortestosterone anabolic-androgenic steroid in an oily depot solution on the WHO Model List of Essential Medicines. It promotes cellular nitrogen retention, stimulates protein synthesis, stimulates renal erythropoietin secretion (enhancing erythropoiesis), and stimulates osteoblastic bone matrix synthesis. Indicated for the adjunctive management of postmenopausal and senile osteoporosis, refractory anemia associated with chronic renal failure, and severe catabolic states / muscle-wasting diseases following extensive trauma or chronic debilitating illness.

Progesterone (Sustained Release Tablets 200mg) is a bioidentical progestogen on the WHO Model List of Essential Medicines. Identical to human ovarian luteal progesterone, it transforms the proliferative endometrium into a secretory endometrium, promotes blastocyst implantation, suppresses myometrial oxytocin receptor expression, and inhibits uterine contractions to maintain pregnancy. Indicated for luteal phase support in assisted reproduction (IVF/ICSI), threatened and recurrent miscarriage, prevention of preterm birth in women with short cervix, secondary amenorrhea, and endometrial protection during estrogen HRT.

Medroxyprogesterone Acetate Tablets IP 10 mg is a synthetic derivative of 17-alpha-hydroxyprogesterone on the WHO Model List of Essential Medicines. It binds to progesterone receptors to transform proliferative endometrium into secretory tissue, reduces endometrial hyperplasia in estrogen replacement regimens, and inhibits gonadotropin production. Indicated for secondary amenorrhea, abnormal uterine bleeding due to hormonal imbalance without organic pathology, endometriosis, and endometrial protection during menopausal estrogen therapy.

Progesterone (Natural Micronised Capsules 100mg/200mg) is a bioidentical progestogen on the WHO Model List of Essential Medicines. Identical to human ovarian luteal progesterone, it transforms the proliferative endometrium into a secretory endometrium, promotes blastocyst implantation, suppresses myometrial oxytocin receptor expression, and inhibits uterine contractions to maintain pregnancy. Indicated for luteal phase support in assisted reproduction (IVF/ICSI), threatened and recurrent miscarriage, prevention of preterm birth in women with short cervix, secondary amenorrhea, and endometrial protection during estrogen HRT.

Progesterone (Natural Micronised Capsules 100mg/200mg) is a bioidentical progestogen on the WHO Model List of Essential Medicines. Identical to human ovarian luteal progesterone, it transforms the proliferative endometrium into a secretory endometrium, promotes blastocyst implantation, suppresses myometrial oxytocin receptor expression, and inhibits uterine contractions to maintain pregnancy. Indicated for luteal phase support in assisted reproduction (IVF/ICSI), threatened and recurrent miscarriage, prevention of preterm birth in women with short cervix, secondary amenorrhea, and endometrial protection during estrogen HRT.

Nandrolone Decanoate Injection IP (25 mg/ml, 50 mg/ml) is a synthetic 19-nortestosterone anabolic-androgenic steroid in an oily depot solution on the WHO Model List of Essential Medicines. It promotes cellular nitrogen retention, stimulates protein synthesis, stimulates renal erythropoietin secretion (enhancing erythropoiesis), and stimulates osteoblastic bone matrix synthesis. Indicated for the adjunctive management of postmenopausal and senile osteoporosis, refractory anemia associated with chronic renal failure, and severe catabolic states / muscle-wasting diseases following extensive trauma or chronic debilitating illness.

Ulipristal Acetate Tablets 5 mg is an orally active, synthetic Selective Progesterone Receptor Modulator (SPRM). It exerts tissue-specific partial agonistic and antagonistic effects on human progesterone receptors, directly suppressing endometrial proliferation, inducing amenorrhea, inhibiting ovulation, and promoting apoptosis in uterine leiomyoma cells, resulting in rapid reduction of uterine fibroid size and heavy menstrual bleeding. Indicated for pre-operative and intermittent medical management of moderate to severe symptoms of uterine fibroids (leiomyomas) in adult women of reproductive age.

Levonorgestrel Tablet IP 1.5 mg is a synthetic second-generation progestogen emergency contraceptive on the WHO Model List of Essential Medicines. When administered during the pre-ovulatory phase, it prevents or delays the LH surge and subsequent follicular rupture/ovulation; it also impairs sperm motility and thickens cervical mucus. Indicated as an emergency post-coital contraceptive within 72 hours (3 days) of unprotected sexual intercourse or known contraceptive failure (e.g. condom breakage, missed pills). It is NOT an abortifacient and will not terminate an established pregnancy.

Progesterone (Injection IP 100mg/2ml) is a bioidentical progestogen on the WHO Model List of Essential Medicines. Identical to human ovarian luteal progesterone, it transforms the proliferative endometrium into a secretory endometrium, promotes blastocyst implantation, suppresses myometrial oxytocin receptor expression, and inhibits uterine contractions to maintain pregnancy. Indicated for luteal phase support in assisted reproduction (IVF/ICSI), threatened and recurrent miscarriage, prevention of preterm birth in women with short cervix, secondary amenorrhea, and endometrial protection during estrogen HRT.

Somatotropin 4 IU (Recombinant Human Growth Hormone - rhGH) Powder for Injection is a biosynthetic 191-amino acid polypeptide hormone produced via recombinant DNA technology, identical to human pituitary growth hormone, on the WHO Model List of Essential Medicines. It stimulates hepatic production of Insulin-like Growth Factor-1 (IGF-1), stimulating chondrocyte proliferation, longitudinal linear skeletal growth in children with open epiphyses, skeletal muscle hypertrophy, lipolysis, and protein synthesis. Indicated for growth hormone deficiency (GHD) in children and adults, Turner syndrome, Prader-Willi syndrome, chronic kidney disease-induced growth failure, and small-for-gestational-age (SGA) children failing to catch up by age 2-4 years.

Norethisterone (Acetate Controlled Release Tablets 10mg) is a potent first-generation synthetic 19-nortestosterone-derived progestogen on the WHO Model List of Essential Medicines. It induces profound secretory transformation of the endometrium and inhibits pituitary gonadotropin release, preventing ovulation and stabilizing the uterine vascular bed. Indicated for the treatment of dysfunctional uterine bleeding (DUB / menorrhagia), endometriosis, postponement of menstruation, secondary amenorrhea, and severe premenstrual syndrome (PMS).